Skip to main content
. 2018 Apr 13;15(6):9264–9270. doi: 10.3892/ol.2018.8492

Figure 1.

Figure 1.

Long non-coding RNA NNT-AS1 is downregulated in human ovarian cancer in vivo and in vitro. (A) RT-qPCR analysis of the expression of NNT-AS1 in clinical human tissues from 55 patients. ***P<0.001 vs. adjacent non-cancerous tissues (Student's t-test). (B) RT-qPCR analysis of the expression of NNT-AS1 in cultured ovarian cancer cell lines. 293T cells were included as a control. *P<0.05 vs. 293T cells (analysis of variance and Student-Newman-Keuls test). RT-qPCR, reverse transcription-quantitative polymerase chain reaction; NNT-AS1, nicotinamide nucleotide transhydrogenase-antisense RNA 1.